DuJChenMYDasanR, et al. Comparison of neovascular age-related macular degeneration outcomes in established vs new patients of a retina practice. J Vitreoretin Dis. 2026;10(1):11-19.
2.
BatesBAMansourHAAl-KhersanH, et al. The efficacy and safety of intravitreal aflibercept 8 mg in clinical practice. J Vitreoretin Dis. 2026;10(1):20-30.
3.
AizoukiCMishraAVLohGK, et al. Characteristics and outcomes of anti–vascular endothelial growth factor therapy in a large cohort of patients with pachychoroid neovasculopathy. J Vitreoretin Dis. 2026;10(1):31-37.
4.
LeungEHKhannaSLaiMM, et al. Economic impact of anti–vascular endothelial growth factor prior authorization process from a large electronic database. J Vitreoretin Dis. 2026;10(1):38-45.
5.
HahnPEichenbaumDDhootDS, et al. Efficacy of intravitreal pegcetacoplan vs avacincaptad pegol in patients with geographic atrophy. J Vitreoretin Dis. 2026;10(1):46-56.
6.
AfkhamnejadERAbdullahZANguyenOMQ, et al. Patient reported experiences and comfort associated with intravitreal injection technique: a cross-sectional survey approach. J Vitreoretin Dis. 2026;10(1):57-67.
7.
GarciaEAdamMKDowE, et al. Artificial intelligence in clinical care: perceptions of retina specialists and patients gathered through a multicenter survey. J Vitreoretin Dis. 2026;10(1):68-73.
8.
BarbosaGCSBalaSMohanN, et al. Real-world functional and anatomic outcomes with aflibercept 8.0 mg in patients with diabetic macular edema. J Vitreoretin Dis. 2026;10(1):74-82.
9.
ZhouAWLeeJEYuHJ, et al. Macular thickness fluctuation as a biomarker: impact on visual acuity following antivascular endothelial growth factor therapy for diabetic macular edema. J Vitreoretin Dis. 2026;10(1):83-89.
10.
GodelSOncelDDonkorRConeyJM.Real-world clinical outcomes after sustained delivery of the 0.19 mg fluocinolone acetonide implant for treatment of diabetic macular edema. J Vitreoretin Dis. 2026;10(1):90-97.
11.
ShirianJDYuanARachitskayaA.Long-term outcomes and patient experiences with the Argus II retinal prosthesis system. J Vitreoretin Dis. 2026;10(1):98-102.
12.
RohowetzLJYiJSGowailyK, et al. Open-globe injuries with retained intraocular foreign bodies: anesthesia options and endophthalmitis rates. J Vitreoretin Dis. 2026;10(1):103-107.
13.
PickelLCruz PimentelMNarmandakhAPereiraAYanP.Retinal detachment in the setting of neurofibromatosis type 1. J Vitreoretin Dis. 2026;10(1):108-115.
14.
SchildrothKRChangJSNorkTM, et al. Intraocular pressure control and long-term outcomes with the reservoir technique: the Wisconsin Silicone Oil Study (Report 2). J Vitreoretin Dis. 2026;10(1):116-121.
15.
NawrockaZNawrockiJ.Swept-source optical coherence tomography angiography after rhegmatogenous retinal detachment treated with different approaches. J Vitreoretin Dis. 2026;10(1):122-129.
16.
SverdlichenkoITayebSCruz PimentelMWahabCNarmandakhAYanP.Sequential management of macular hole-associated rhegmatogenous retinal detachment: case report and literature review. J Vitreoretin Dis. 2026;10(1):130-138.
17.
UpadhyayaANarulaRTakkarB.Structural and functional improvement in persistent macular edema following internal limiting membrane peeling coupled with integrated optical coherence tomography-guided cyst puncture of intracystic hyperreflective material. J Vitreoretin Dis. 2026;10(1):139-144.
18.
YamamotoMHAuAGiaconiJTsuiI.Spontaneous crystalline lens dislocation associated with pseudoexfoliation glaucoma: an unexpected complication of vitrectomy. J Vitreoretin Dis. 2026;10(1):145-148.
19.
MitchellMKPfannenstielMMAjlanRS.Bimanual endoscopic pars plana vitrectomy technique. J Vitreoretin Dis. 2026;10(1):149-152.
20.
FlynnECheelaIKadenTR.Female carrier of ocular albinism linked to Gpr143 gene. J Vitreoretin Dis. 2026;10(1):153-156.
ChawlaHMorrisRESappMRBaxterCRSahawnehMJKuhnF.Subacute Terson syndrome in a patient with monocular vision after craniofacial ballistic injury. J Vitreoretin Dis. 2026;10(1):162-165.
23.
MusheyevBBarmas-AlamdariDHarelAHarshanMLiAS.Retinal vasculitis as an initial presentation of atypical neurosarcoidosis with occult central nervous system inflammation. J Vitreoretin Dis. 2026;10(1):166-172.
24.
SkrehotHCAlsoudiAOlsonDLeNLoyaAScholleT.Bilateral concomitant infection of cytomegalovirus and varicella-zoster virus retinitis in an immunocompromised adult. J Vitreoretin Dis. 2026;10(1):173-176.
25.
PericakJChinEKAlmeidaDRP. Scleritis secondary to eosinophilic granulomatosis with polyangiitis. J Vitreoretin Dis. 2026;10(1):177-179.
26.
SelyaA.Associations between electronic cigarettes, smokeless tobacco, and age-related macular degeneration in the 2017 United States National Health Interview Survey. J Vitreoretin Dis. 2026;10(1):180-181.
27.
YousufSJ.Associations between electronic cigarettes, smokeless tobacco, and age-related macular degeneration in the 2017 United States National Health Interview Survey – reply. J Vitreoretin Dis. 2026;10(1):182.
